Insider · CIK 0001833033
Paul Gray Parker
Files at GENB (Generate Biomedicines, Inc.). First filing -, latest -.
In brief
Paul Gray Parker files SEC Form 4 as director at GENB (Generate Biomedicines, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Paul Gray Parker has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | GENB Generate Biomedicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +29,561 | $0.00 | $0 | 29,561 | Mar 2, 2026 |
Questions about Paul Gray Parker
Answered from the filings on this page, as of the latest one.
Is Paul Gray Parker buying or selling?
Paul Gray Parker has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Paul Gray Parker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul Gray Parker has 0.
Where does Paul Gray Parker file Form 4?
Paul Gray Parker has filed Form 4 at GENB (Generate Biomedicines, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.